Equity Incentive Plans and Stock-Based Compensation - Summary of the Activity Under the Stock Plan (Details) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Share-based Payment Arrangement [Abstract]
Shares Available for Grant, Beginning balance | shares	29,375,026	66,252,927
Beginning Balance, Shares Recapitalization | shares	38,002,437
Balance as of March 31, 2021 | shares	67,377,463	66,252,927
Stock Options, Granted | shares		4,798,281
Shares Available for Grant, Exercised | shares		(3,945,200)
Shares Available for Grant, Cancelled/Forfeited/Expired | shares		(1,977,617)
Shares Available for Grant, Ending balance | shares	29,375,026	66,252,927
Ending Vested and exercisable, Shares Available for Grant | shares		42,160,416
Weighted-Average Exercise Price, Beginning balance | $ / shares	$ 9.37	$ 4.14
Weighted-Average Exercise Price, Recapitalization | $ / shares	(5.28)
Balance as of March 31, 2021 | $ / shares	4.09
Weighted-Average Exercise Price, Granted | $ / shares		4.69
Weighted-Average Exercise Price, Exercised | $ / shares		3.49
Weighted-Average Exercise Price, Cancelled/Forfeited/Expired | $ / shares		4.80
Weighted-Average Exercise Price, Ending balance | $ / shares	$ 9.37	4.14
Weighted-Average Exercise Price, Vested and exercisable | $ / shares		$ 3.68
Weighted-Average Remaining Contractual Term (Years)	7 years 1 month 6 days	6 years 6 months
Weighted-Average Remaining Contractual Term (Years), Vested and Exercisable		5 years 8 months 12 days
Aggregate Intrinsic Value of Options Outstanding | $	$ 403,498	$ 175,006
Aggregate Intrinsic Value of Options Outstanding, Vested and Exercisable | $		$ 125,733